Yasmin Sultana
Overview
Explore the profile of Yasmin Sultana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nirwan N, Anjaneyulu Y, Sultana Y, Vohora D
J Drug Target
. 2025 Feb;
:1-12.
PMID: 39945334
Osteoporosis is a common metabolic bone disorder that requires new treatment strategies. Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is a proven osteogenic agent in diabetes-linked bone loss. However, poor solubility,...
2.
Emad N, Pandit J, Ali A, Rathee A, Solanki P, Imtiyaz K, et al.
Int J Biol Macromol
. 2025 Jan;
298:139997.
PMID: 39848215
No abstract available.
3.
Emad N, Pandit J, Ali A, Rathee A, Solanki P, Imtiyaz K, et al.
Int J Biol Macromol
. 2024 Dec;
288:138500.
PMID: 39647739
Diabetic foot ulcer (DFU) is a complicated pathophysiological process, and there is now no recognized treatment. Hyperglycemia, neuropathy, impaired angiogenesis, reactive oxygen species, and advanced glycation end products construct the...
4.
Ali A, Emad N, Sultana N, Waheed A, Aqil M, Sultana Y, et al.
CNS Neurol Disord Drug Targets
. 2024 Oct;
PMID: 39400020
Repurposing drugs for neurodegenerative diseases using the nose-to-brain route of administration is an intriguing concept with potential benefits. The nose-to-brain route involves delivering drugs directly to the brain via the...
5.
Ali A, Emad N, Sultana N, Ali H, Jahan S, Aqil M, et al.
Iran J Basic Med Sci
. 2024 Sep;
27(10):1228-1242.
PMID: 39229578
Natural herbs have garnered significant research recently as their components target multiple disease signaling pathways, making them highly potential for various disease prevention and treatment. Embelin, a naturally occurring benzoquinone...
6.
Gupta P, Sharma S, Gupta A, Kawish S, Iqbal M, Rahman S, et al.
ACS Omega
. 2024 Jul;
9(28):30120-30130.
PMID: 39035924
The present study describes the development and validation of a simple and rapid HPLC method for the simultaneous quantification of exemestane and thymoquinone. The separation of both compounds was performed...
7.
Rathee A, Solanki P, Emad N, Zai I, Ahmad S, Alam S, et al.
Sci Rep
. 2024 Jul;
14(1):16588.
PMID: 39025925
Invasive fungal infections (IFI) pose a significant health burden, leading to high morbidity, mortality, and treatment costs. This study aims to develop and characterize nanomicelles for the codelivery of posaconazole...
8.
Sultana Y, Kaur Lang D, Santosh Alex T, Khabiya R, Dwivedi A, Sen S, et al.
Cardiovasc Hematol Agents Med Chem
. 2024 Mar;
PMID: 38549520
Overproduction of reactive nitrogen and oxygen species (RNS and ROS) has been linked to the pathogenesis of diabetes, hypertension, hyperlipidemia, stroke, angina, and other cardiovascular diseases. These species are produced...
9.
Ansari M, Shafi S, Pandit J, Waheed A, Jahan R, Khan I, et al.
Drug Deliv Transl Res
. 2023 Nov;
14(6):1635-1647.
PMID: 37996726
This research work is to evaluate spanlastic-loaded raloxifene (RLX) nanogel administration via the transdermal route to avoid its hepatic metabolism and to enhance the bioavailability for better management of osteoporosis....
10.
Jahan R, Khan Z, Akhtar M, Ansari M, Solanki P, Ahmad F, et al.
Antibiotics (Basel)
. 2023 Oct;
12(10).
PMID: 37887211
The ever-growing emergence of antibiotic resistance associated with tuberculosis (TB) has become a global challenge. In 2012, the USFDA gave expedited approval to bedaquiline (BDQ) as a new treatment for...